Sanofi (0O59, SNY) → Stock, financial statements
Advertising

Sanofi: stocks, financial statements

Dividends News
Favorites

Engages in the research, production and distribution of pharmaceutical products

  • 0O59, SNY Ticker
  • 🇬🇧 LSE, 🇺🇸 NASDAQ Exchange
  • 104,226 Employees
18 rated
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon

Financial statements — Sanofi

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
46B 42B 41B 43B 37B
Cost Of Revenue
15B 13B 13B 14B 11B
Gross Profit
31B 29B 28B 29B 25B
Research and Development
6.8B 6.7B 6.7B 6.5B 5.5B
Selling General and Admin
12B 11B 11B 12B 10B
Operating Expense
37B 35B 34B 35B 29B
Operating Income
8.8B 7.2B 6.6B 8.3B 7.6B
Other Income Expense Net
860M 920M 550M 280M 370M
EBIT
10B 8.4B 7.7B 8.7B 8.1B
Interest Income
410M 240M 310M 330M 230M
Pretax Income
17B 3.4B 5.6B 6.7B 6.1B
Income Tax
2.2B 160M 550M 2.1B 1.4B
Minority Interest
44M 35M 120M 140M 96M
Net Income
15B 3.1B 4.9B 10B 5B
Net Income Basic
15B 3.1B 4.9B 10B 5B
20 ← 16 2020 2019 2018 2017 2016
Current cash
18B 11B 8.1B 12B 11B
Short term investments
2.2B 2.3B 2.4B 560M 470M
Receivables
11B 9.7B 9B 10B 9.6B
Inventory
10B 9B 8.5B 8.1B 7.3B
Other current assets
2.2B 2.3B 2.4B 560M 470M
Current assets
41B 32B 28B 31B 28B
Long term investments
99B 94B 99B 88B 82B
Property plant equipment
12B 11B 11B 11B 11B
Goodwill
55B 50B 51B 48B 43B
Intangible assets
23B 19B 25B 16B 11B
Other assets
4B 3.4B 2.6B 1B 960M
Total assets
140B 130B 130B 120B 110B
Accounts payable
6.5B 6B 5.8B 5.5B 4.5B
Current long term debt
3.7B 5.4B 3B 1.5B 1.9B
Other current liabilities
13B 11B 11B 11B 11B
Total current liabilities
24B 23B 20B 18B 17B
Long term debt
25B 24B 25B 17B 18B
Other liabilities
11B 10B 9.8B 11B 9.3B
Minority Interest
660M 760M 1.3B 1.4B 1.6B
Total Liabilities
63B 60B 60B 50B 50B
Common stock
2.5B 2.5B 2.5B 2.5B 2.6B
Retained earning
74B 58B 0 0 0
Treasury stock
-870M -10M -170M -17M -1.6B
Capital surplus
Shareholder equity
77B 66B 67B 69B 61B
Net tangible assets
270M -2.4B -8.3B 5.7B 6.7B
20 ← 16 2020 2019 2018 2017 2016
Net Income
15B 3.1B 4.9B 10B 5B
Depreciation
4.5B 8.4B 4.9B 4.4B 3.5B
Changes in receivables
1B 700M -1.3B 800M -100M
Changes in inventories
1.3B 410M 410M 860M 170M
Cash change
7.2B 2.9B -4.3B 1.5B 880M
Cash flow
9.2B 8.7B 6.3B 8.8B 8.6B
Capital expenditures
-2.6B -2B -2.3B -2.3B -2.2B
Investments
Investing activity other
Total investing cash flows
-4.4B -1.4B -15B -3.5B -2.8B
Dividends paid
Net borrowings
8.7B 16B 18B 5.7B 8.3B
Other financing cash flows
Cash flow financing
-8B -4.7B 4.5B -9.4B -4.2B
Exchange rate effect